Aripiprazole in young people with early psychosis: a systematic review and meta-analysis of weight gain

Arti Parmar, Donald Hulme, Daniel Hacking, Gordon Shymko, Milan Dragovic, Grace Terina, Flavie Waters

Research output: Contribution to journalReview articlepeer-review

Abstract

Objective: Aripiprazole is often prescribed to young people, although there remain unanswered questions about its effects on weight gain. This study undertook a meta-analysis of weight gain occurring in young people with early psychosis who were prescribed aripiprazole. Method: A systematic search was conducted for studies reporting on aripiprazole and weight change in young people with a psychotic disorder. A meta-analysis integrated the data into an estimate of effect size. Results: Eleven studies met the inclusion criteria amounting to 886 participants (mean age 18 years). The results showed significant weight gain averaging 2.7 kg. These increases were associated with a longer duration of exposure to aripiprazole but not a higher dosage. Conclusions: The results highlight the importance of regular patient monitoring and the early implementation of interventions to manage antipsychotic-related weight gain.

Original languageEnglish
Article number10398562211037334
Pages (from-to)90-94
Number of pages5
JournalAustralasian Psychiatry
Volume30
Issue number1
DOIs
Publication statusPublished - Feb 2022

Fingerprint

Dive into the research topics of 'Aripiprazole in young people with early psychosis: a systematic review and meta-analysis of weight gain'. Together they form a unique fingerprint.

Cite this